184 related articles for article (PubMed ID: 36759323)
1. Correlation between partial thromboplastin time and thromboelastography in adult critically ill patients requiring bivalirudin for extracorporeal membrane oxygenation.
Buckley MS; Benanti GE; Meckel J; Tekle LA; Gilbert B; Puebla Neira D; McNierney DA; Korkames G; Yerondopoulos M; Park A; O'Hea JA; MacLaren R
Pharmacotherapy; 2023 Mar; 43(3):196-204. PubMed ID: 36759323
[TBL] [Abstract][Full Text] [Related]
2. A perioperative bivalirudin anticoagulation protocol for neonates with congenital diaphragmatic hernia on extracorporeal membrane oxygenation.
Snyder CW; Goldenberg NA; Nguyen ATH; Smithers CJ; Kays DW
Thromb Res; 2020 Sep; 193():198-203. PubMed ID: 32763642
[TBL] [Abstract][Full Text] [Related]
3. Bivalirudin Anticoagulation Dosing Protocol for Extracorporeal Membrane Oxygenation: A Retrospective Review.
Netley J; Roy J; Greenlee J; Hart S; Todt M; Statz B
J Extra Corpor Technol; 2018 Sep; 50(3):161-166. PubMed ID: 30250342
[TBL] [Abstract][Full Text] [Related]
4. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
[TBL] [Abstract][Full Text] [Related]
5. Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: Thromboelastometry versus routine coagulation testing.
Teruya J; Hensch L; Bruzdoski K; Adachi I; Hui SR; Kostousov V
Thromb Res; 2020 Feb; 186():54-57. PubMed ID: 31884000
[TBL] [Abstract][Full Text] [Related]
6. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO).
Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ
Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718
[TBL] [Abstract][Full Text] [Related]
7. Poor Reliability of Common Measures of Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation.
Rabinowitz EJ; Ouyang A; Armstrong DR; Wallendorf M; Said AS
ASAIO J; 2022 Jun; 68(6):850-858. PubMed ID: 34581287
[TBL] [Abstract][Full Text] [Related]
8. Correlation between heparin anti-Xa activity and thromboelastography in adult critically ill COVID-19 patients.
Buckley MS; Benanti GE; Gilbert B; Meckel J; Dzierba AL; MacLaren R
Pharmacotherapy; 2023 Aug; 43(8):795-803. PubMed ID: 37199139
[TBL] [Abstract][Full Text] [Related]
9. Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: a safety and feasibility pilot study.
Panigada M; E Iapichino G; Brioni M; Panarello G; Protti A; Grasselli G; Occhipinti G; Novembrino C; Consonni D; Arcadipane A; Gattinoni L; Pesenti A
Ann Intensive Care; 2018 Jan; 8(1):7. PubMed ID: 29340875
[TBL] [Abstract][Full Text] [Related]
10. Heparin-like effect in postcardiotomy extracorporeal membrane oxygenation patients.
Ranucci M; Baryshnikova E; Isgrò G; Carlucci C; Cotza M; Carboni G; Ballotta A
Crit Care; 2014 Sep; 18(5):504. PubMed ID: 25189998
[TBL] [Abstract][Full Text] [Related]
11. Description of Bivalirudin Use for Anticoagulation in Pediatric Patients on Mechanical Circulatory Support.
Campbell CT; Diaz L; Kelly B
Ann Pharmacother; 2021 Jan; 55(1):59-64. PubMed ID: 32590908
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Bivalirudin for Therapeutic Anticoagulation in COVID-19 Patients Requiring ECMO Support.
Trigonis R; Smith N; Porter S; Anderson E; Jennings M; Kapoor R; Hage C; Moiz S; Garcia J; Rahman O
J Cardiothorac Vasc Anesth; 2022 Feb; 36(2):414-418. PubMed ID: 34782234
[TBL] [Abstract][Full Text] [Related]
13. How to best monitor bivalirudin anticoagulant effect for ECMO and VAD-Comparison of four assay methods.
Teruya J; Bruzdoski K; Hensch L; Hui SR; Kostousov V
Int J Lab Hematol; 2022 Jun; 44(3):589-594. PubMed ID: 34939341
[TBL] [Abstract][Full Text] [Related]
14. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.
Ranucci M; Ballotta A; Kandil H; Isgrò G; Carlucci C; Baryshnikova E; Pistuddi V;
Crit Care; 2011; 15(6):R275. PubMed ID: 22099212
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation.
Seelhammer TG; Brokmeier HM; Hamzah M; Wieruszewski PM
Crit Care Med; 2023 May; 51(5):e115-e121. PubMed ID: 36853326
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction.
Kiser TH; Fish DN
Pharmacotherapy; 2006 Apr; 26(4):452-60. PubMed ID: 16553502
[TBL] [Abstract][Full Text] [Related]
17. Management of Bivalirudin Dosing and Replacement Fluid During Therapeutic Plasma Exchange in Children on Extracorporeal Membrane Oxygenation.
Chomat MR; Swanson K; Barton K; Douds M; Said AS
ASAIO J; 2024 Mar; 70(3):e31-e37. PubMed ID: 38029748
[TBL] [Abstract][Full Text] [Related]
18. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P
J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330
[TBL] [Abstract][Full Text] [Related]
19. Thromboelastometry, Thromboelastography, and Conventional Tests to Assess Anticoagulation During Extracorporeal Support: A Prospective Observational Study.
Giani M; Russotto V; Pozzi M; Forlini C; Fornasari C; Villa S; Avalli L; Rona R; Foti G
ASAIO J; 2021 Feb; 67(2):196-200. PubMed ID: 33512915
[TBL] [Abstract][Full Text] [Related]
20. Bivalirudin May Reduce the Need for Red Blood Cell Transfusion in Pediatric Cardiac Patients on Extracorporeal Membrane Oxygenation.
Machado DS; Garvan C; Philip J; Harrington D; Spiess B; Kelly B; Campbell CT; Pelletier JPR; Islam S; Peek GJ; Bleiweis MS
ASAIO J; 2021 Jun; 67(6):688-696. PubMed ID: 33031157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
